Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Acne Age: Adult |
Dose: Topical/Cutaneous – Apply onto affected areas Frequency: 1-2 times daily Note: Discontinue treatment if condition worsens or if there is no improvement after 6-8 weeks of continuous usage. Maximum duration: 6 months. |
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Form – Safety and efficacy not established |
| Drug Name | Risk Factors |
|---|---|
|
Colchicine
|
Increased risk of toxicity
|
|
HMG-CoA reductase inhibitors (e.g. simvastatin)
|
Rhabdomyolysis with or without renal impairment
|
| Disease Name | Risk Factors |
|---|---|
|
Porphyria
|
Can trigger acute attacks
|
|
Hepatic Impairment
|
Can worsen liver function
|
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.